SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-08-003420
Filing Date
2008-05-16
Accepted
2008-05-16 14:19:39
Documents
1
Period of Report
2008-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 edgar123.html 4  
1 FORM 4 edgar123.xml 4 4659
  Complete submission text file 0001005477-08-003420.txt   6744
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O CYCLACEL PHARMACEUTICALS, INC. 150 JOHN F. KENNEDY PARKWAY, SUITE 100 SHORT HILLS NJ 07078
Business Address 973-847-5955
Rombotis Spiro George (Reporting) CIK: 0001357396 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 08841649